[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[ccp4bb] PhD opportunity at Research Complex at Harwell/University of Nottingham
An exciting, MRC funded, PhD opportunity to investigating the structural biology of brain development is available at the Research Complex at Harwell/University of Nottingham. If you know of any talented undergraduate or masters students might be interested I would be grateful if you could point them towards this advertisment.
MRC Integrated Midlands Partnership for Biomedical Training (IMPACT<http://www.birmingham.ac.uk/schools/mds-graduate-school/scholarships/mrc-impact/index.aspx>
Full details of application:
(closing date 16 January 2017).
UBE3A and UBE3A partner protein complexes
David Scott<https://www.nottingham.ac.uk/biosciences/people/david.scott>, Robert Layfield<https://www.nottingham.ac.uk/life-sciences/people/robert.layfield> and Stephen Carr<http://www.rc-harwell.ac.uk/Team-MembersCarr>
Summary: This PhD project represents a unique opportunity to combine multi-disciplinary training on leading edge techniques at World class facilities with providing crucially important insight into both the healthy and disease state in an important aspect of human biology. Importantly, the project will provide the student with an appreciation of the value of studying protein-protein interactions on a firm structural, quantitative and functional footing.
UBE3A is an E3 ubiquitin ligase expressed in the human brain whose deficit and incorrect function is associated with several diseases, most notably Angelman syndrome. It also interacts with E6 protein of HPV, as well as being part of larger complexes associated with circardian rhythms.
This PhD project is to understand how UBE3A and its complexes work, and in order to do this we need a detailed picture of UBE3A and its complexes at the molecular level. We will employ protein crystallography and cutting-edge electron microscopy in order to obtain structural and biological information.
The Scott, Layfield and Carr laboratories provide a rich, diverse, supportive and active research environment. The student will be expected to be resident for at least 50-80 % Research Complex at Harwell (www.rc-harwell.ac.uk<http://www.rc-harwell.ac.uk/>), where there will be training in protein expression, purification, protein crystallography and electron microscopy. At Nottingham there will be functional pulldown assays in order to assess further binding partners as well as in vitro ubiquitination assays. All facilities are staffed by expert technical staff with post-doctoral qualifications who are available for training and experimental design during the course of this studentship.
Any queries please email: firstname.lastname@example.org<mailto:email@example.com?subject=MRC%20Impact%20PhD%20position%20enquiry>
* Those who have a 1st or a 2.1 undergraduate degree in a relevant field are eligible.
* Those who have a 2.2 and an additional Masters degree (Merit or Distinction) in a relevant field may be eligible.
* Those who have a 2.2 and at least three years postgraduate experience in a relevant field may be eligible.
* Those with degrees abroad (perhaps as well as postgraduate experience) may be eligible if their qualifications are deemed equivalent to any of the above
Dr Stephen Carr
Research Complex at Harwell (RCaH)
Rutherford Appleton Laboratory
Oxon OX11 0FA
tel 01235 567717
This email and any attachments may contain confidential, copyright and or privileged material, and are for the use of the intended addressee only. If you are not the intended addressee or an authorized recipient of the addressee, please notify us of receipt by returning the e-mail and do not use, copy, retain, distribute or disclose the information in or attached to this email.
Any views or opinions presented are solely those of the author and do not necessarily represent those of the Research Complex at Harwell.
There is no guarantee that this email or any attachments are free from viruses and we cannot accept liability for any damage which you may sustain as a result of software viruses which may be transmitted in or with the message.
We use an electronic filing system. Please send electronic versions of documents, unless paper is specifically requested.
This email may have a protective marking, for an explanation, please see: